Palvella Therapeutics (NASDAQ:PVLA) Receives Average Rating of “Buy” from Brokerages
Shares of Palvella Therapeutics (NASDAQ:PVLA – Get Free Report) have been assigned an average recommendation of “Buy” from the eight analysts that are presently covering the company, MarketBeat reports. Seven equities research analysts have rated the stock with a buy recommendation and one has assigned a strong buy recommendation to the company. The average 12-month […]
Shares of Palvella Therapeutics (NASDAQ:PVLA – Get Free Report) have been assigned an average recommendation of “Buy” from the eight analysts that are presently covering the company, MarketBeat reports. Seven equities research analysts have rated the stock with a buy recommendation and one has assigned a strong buy recommendation to the company. The average 12-month […]
